Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
UBS
AstraZeneca
Julphar
Mallinckrodt
Johnson and Johnson
McKinsey
Citi
Dow
Healthtrust

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019641

« Back to Dashboard
NDA 019641 describes TERAZOL 3, which is a drug marketed by Janssen Pharms and is included in two NDAs. It is available from four suppliers. Additional details are available on the TERAZOL 3 profile page.

The generic ingredient in TERAZOL 3 is terconazole. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the terconazole profile page.

Summary for NDA: 019641

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Pharmacology for NDA: 019641

Ingredient-typeAzoles

Suppliers and Packaging for NDA: 019641

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TERAZOL 3
terconazole
SUPPOSITORY;VAGINAL 019641 NDA Janssen Pharmaceuticals, Inc. 50458-531 50458-531-01 1 DOSE PACK in 1 CARTON (50458-531-01) > 3 SUPPOSITORY in 1 DOSE PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUPPOSITORY;VAGINALStrength80MG
Approval Date:May 24, 1988TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 019641

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
TERAZOL 3
terconazole
SUPPOSITORY;VAGINAL019641-001May 24, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Dow
Moodys
Argus Health
QuintilesIMS
US Army
Julphar
Teva
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot